New Zealand Markets closed

Valaris Limited (VAL)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
65.06+0.42 (+0.65%)
At close: 04:00PM EDT
65.06 +0.02 (+0.03%)
After hours: 04:07PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 380.00
52-week low 337.17
50-day moving average 369.99
200-day moving average 359.20

Share statistics

Avg vol (3-month) 31.1M
Avg vol (10-day) 3943.16k
Shares outstanding 575.18M
Implied shares outstanding 6N/A
Float 855.21M
% held by insiders 17.43%
% held by institutions 186.80%
Shares short (12 Jan 2023) 43.12M
Short ratio (12 Jan 2023) 45.53
Short % of float (12 Jan 2023) 44.75%
Short % of shares outstanding (12 Jan 2023) 44.15%
Shares short (prior month 14 Dec 2022) 42.53M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:4
Last split date 310 Apr 2019

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022

Profitability

Profit margin 11.87%
Operating margin (ttm)0.41%

Management effectiveness

Return on assets (ttm)0.14%
Return on equity (ttm)15.79%

Income statement

Revenue (ttm)1.47B
Revenue per share (ttm)19.67
Quarterly revenue growth (yoy)33.80%
Gross profit (ttm)159.9M
EBITDA 91M
Net income avi to common (ttm)175M
Diluted EPS (ttm)-13.84
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)626M
Total cash per share (mrq)8.33
Total debt (mrq)551.5M
Total debt/equity (mrq)45.19
Current ratio (mrq)2.59
Book value per share (mrq)17.34

Cash flow statement

Operating cash flow (ttm)-34.2M
Levered free cash flow (ttm)-120.51M